Director, Pharmacovigilance & Safety Technology

Overview

Alnylam is the world’s leading RNA interference (RNAi) company, dedicated to transforming patients’ lives through innovative medicines. As the global development and commercial portfolio expands, Safety & Risk Management requires scalable, compliant, and data-driven technology capabilities that support high-quality pharmacovigilance across investigational and marketed products.

The Director, Pharmacovigilance & Safety Technology shapes and executes the technology strategy for Safety & Risk Management and related safety functions. As the primary business technology leader for Safety, this role ensures that platforms, data, integrations, analytics, reporting, and digital workflows enable compliant, efficient, inspection-ready, and insight-driven operations across the product lifecycle.

Reporting to the Executive Director, Commercial & Development Technologies, this role directly manages two experienced technology professionals at the Manager and Senior Manager levels. The role translates Safety priorities into a practical roadmap and leads execution and additional work through its team, product owners, application teams, managed service providers, vendors, and cross-functional partners.

Success in this role requires strong pharmacovigilance-domain business acumen, technical fluency across regulated safety platforms, and the ability to translate safety priorities into a practical technology roadmap. The leader will be expected to connect strategy to execution—partnering with Safety leadership, enterprise Technology, Data, Quality, Security, Compliance, Validat